Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-01-01 @ 11:10 PM
Study NCT ID:
NCT01244958
Status:
COMPLETED
Last Update Posted:
2016-03-24
First Post:
2010-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis
Sponsor:
Frank Behrens
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FFM07-Rtx-Lef
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None